Date clarification: Dow is scheduled to report today, Thursday, July 23, 2026, before the U.S. market opens—not tomorrow. This preview is framed around the setup immediately ahead of that release and the associated 2026Q2 earnings call.
Dow enters 2Q earnings with a sharply improved near-term earnings setup versus 1Q, driven principally by petrochemical pricing, tighter global supply, higher utilization in its advantaged Americas assets, and early cost-program benefits. However, the crucial issue is no longer whether EBITDA rebounds sequentially—management explicitly guided to it. The debate is whether Dow can exceed its $2.0 billion EBITDA outlook and, more importantly, sustain a higher earnings base if Middle East-related supply disruption fades.
The stock appears to reflect substantial skepticism. DOW closed at $31.26 on July 22, down roughly 19% since April 22 and about 23% below its May 5 closing high. The market’s concern is that current pricing upside is transient and that Dow’s underlying cycle, balance sheet, and credit profile remain challenged.
My read: results should be meaningfully better sequentially, but the stock reaction will hinge on the durability of pricing/margins, the 3Q outlook, and whether the new CEO offers a credible path to cash generation and deleveraging.
| Metric | 1Q26 actual | Dow’s 2Q26 outlook | Street expectation entering the print |
|---|---|---|---|
| Net sales | $9.8B | ~$12.0B | $11.95B |
| Operating EBITDA | $873M | ~$2.0B | $2.2B |
| Operating EPS | $(0.14) | Not formally guided | $1.26 |
Dow’s own outlook implies sales growth of about 23% sequentially and EBITDA growth of about 129% sequentially. But consensus EBITDA is already 10% above the company’s stated $2.0B outlook.
Implication: A “beat” against 1Q or against the company’s $2.0B guide may not be enough. Investors will want evidence that the upside embedded in unmodeled May pricing actions, higher operating rates, and cost savings can close or exceed the gap to the $2.2B Street number.
At its April 23 earnings call, Dow guided to approximately $12B of 2Q revenue and $2B of operating EBITDA. The bridge was expected to be driven by:
The centerpiece is Packaging & Specialty Plastics (P&SP). Management indicated that the 2Q setup included approximately $0.26/lb of global integrated-margin improvement, with the April polyethylene pricing action included in its outlook but the May increase not included—creating the potential for upside if realization held. Management also discussed P&SP EBITDA of roughly $1.75B for 2Q, making that segment the central earnings variable.
This is the dominant question. Dow entered 2026 with depressed petrochemical pricing, particularly in polyethylene, and 1Q reflected that weakness: companywide local price was down 7% year over year, P&SP price was down 9%, and operating EBITDA was only $873M.
The Middle East conflict subsequently disrupted chemical feedstocks, logistics, and product availability, particularly for Asia and Europe. Dow believes its North American ethane-based footprint, Americas production scale, European feedstock flexibility, and new Freeport polyethylene capacity allow it to capture disproportionate benefits from tighter supply and higher global pricing.
A strong 2Q could validate Dow’s position as a major beneficiary of the supply shock. But a quick normalization in Middle East logistics or a reversal in oil/naphtha-driven pricing would challenge the durability of elevated margins—especially in a market that appears unwilling to capitalize a short-lived windfall.
Dow’s operational recovery is not solely macro-driven. The company has layered several self-help programs on top of the cycle:
In 1Q, Dow reported approximately $193M of period cost savings. It expects transformation benefits to ramp materially in the second half, including roughly $400M of incremental value in 2H26.
Investor takeaway: A durable rerating requires Dow to demonstrate that a meaningful share of earnings improvement can survive a normalization in spreads.
P&SP should carry the quarter, but investors should assess whether Dow’s recovery is broad-based.
The likely earnings engine. Higher polyethylene volumes, the Freeport Poly-7 unit, strong Americas utilization, and price realization should produce the largest sequential step-up.
This business remains less clean. In 1Q, the segment posted an operating EBIT loss of $118M, despite lower maintenance costs, cost savings, and suspended Sadara loss recognition. Construction-related demand remained weak, while planned maintenance and lower licensing revenue were expected to mute 2Q improvement.
This was Dow’s relative bright spot in 1Q: EBIT rose to $117M from $49M a year earlier, supported by downstream silicones, electronics, acrylic-monomer volume, and lower fixed costs. The issue for 2Q is whether propylene/feedstock inflation and softer building-and-construction demand limit seasonal upside.
A strong report should show more than a P&SP rebound. Investors will look for: - Positive operating leverage in Industrial Intermediates; - Continued growth in downstream silicones/electronics; - Stable or improving Europe profitability; - Limited demand destruction in construction, mobility, and consumer-linked end markets.
Dow’s 1Q free cash flow was $621M, but it was flattered by approximately $1B of net cash proceeds related to the Nova Chemicals litigation. That cash receipt should not be annualized as operating performance.
At March 31, Dow reported:
The balance sheet is liquid, but leverage remains material. Standard & Poor’s downgraded TDCC to BBB- in February 2026 with a negative outlook, while Moody’s downgraded it to Baa3 with a negative outlook. Fitch maintained a BBB rating with a stable outlook.
Sadara is another overhang. Dow suspended recognition of further equity losses under GAAP after cumulative losses reached its relevant obligations and commitments. Management previously characterized the ongoing cash commitment as roughly $100M annually through 2038, but investors will seek a clearer update on restructuring discussions with Saudi Aramco, operational recovery, and ultimate liability.
Karen S. Carter became CEO effective July 1, 2026, with Jim Fitterling moving to Executive Chair. This will be the first quarterly report presented under Carter’s leadership.
The transition appears designed for continuity rather than a strategic reset. Still, the call matters because investors will want to hear Carter’s priorities in three areas:
A clear, specific operating framework could help reduce uncertainty around Dow’s post-Fitterling execution story.
Potential market interpretation: Dow’s Americas advantage and cost program are producing a more durable earnings reset than expected.
Potential market interpretation: Operational improvement is real, but largely anticipated; the stock response depends on whether the call supports a sustained 2027 earnings base.
Potential market interpretation: The 2Q rebound was a temporary geopolitical price spike rather than a structural recovery.
Dow’s 2Q26 report should show a dramatic sequential earnings recovery. The key challenge is that consensus already expects more than management’s formal EBITDA guide, while the market appears unconvinced that conflict-driven pricing is durable.
For the stock, the most constructive outcome is not simply a strong 2Q print. It is a report that combines pricing upside, P&SP margin strength, credible self-help execution, improved cash conversion, and a disciplined 3Q/2027 framework. Conversely, any indication that higher prices are fading quickly—or that the earnings improvement is not translating into cash and balance-sheet repair—would reinforce the market’s skepticism.